Quarterly report pursuant to Section 13 or 15(d)

Note 6 - Stock-based Compensation

Note 6 - Stock-based Compensation

9 Months Ended

Sep. 30, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

6 .	Stock-Based Compensation

For the

three

-month periods ended

September 30, 2018

and

2017,

our total stock-based compensation expense, which includes reversals of expense for certain forfeited or cancelled awards, was approximately

$44,000

and

$64,000,

respectively. For the

nine

-month periods ended

September 30, 2018

and

2017,

our total stock-based compensation expense, which includes reversals of expense for certain forfeited or cancelled awards, was approximately

$261,000

and

$320,000,

respectively. We have

not

recorded any income tax benefit related to stock-based compensation in any of the

three

-month or

nine

-month periods ended

September 30, 2018

and

2017.

A summary of the status of our stock options as of

September 30, 2018,

and changes during the

nine

-month period then ended, is presented below:

	Nine Months Ended September 30, 2018
	Number of Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (in years)		Aggregate Intrinsic Value
Outstanding at beginning of period		3,687,679		$	1.50
Granted		470,000			0.53
Exercised		—			—
Canceled and Forfeited		(116,000	)		0.71
Expired		(7,000	)		0.66
Outstanding at end of period		4,034,679		$	1.41		6.3	$	—
Exercisable at end of period		2,260,683		$	2.00		4.3	$	—

A summary of the status of our unvested restricted stock as of

September 30, 2018,

and changes during the

nine

-month period then ended, is presented below:

	Nine Months Ended September 30, 2018
	Number of Shares			Weighted Average Grant-Date Fair Value
Unvested at beginning of period		150,000		$	0.51
Granted		200,000			0.37
Vested		(200,000	)		0.47
Forfeited		(50,000	)		0.36
Unvested at end of period		100,000		$	0.37

As of

September 30, 2018,

there was approximately

$101,000

of total unrecognized compensation expense related to unvested stock-based awards, which we expect to recognize over the remaining weighted average vesting term of approximately

1.2

years.